Search for: "Mylan Pharmaceuticals"
Results 301 - 320
of 739
Sort by Relevance
|
Sort by Date
14 Apr 2015, 8:34 pm
The Federal Circuit found that Apotex has a concrete, potentially high-value stake in obtaining a declaratory judgment, and that both Daiichi and generic manufacturer Mylan Pharmaceuticals, Inc. have a concrete, potentially high-value stake in denying Apotex that judgment and thereby delaying Apotex’s market entry. [read post]
2 Apr 2015, 9:59 pm
The first filer, Mylan Pharmaceuticals, Inc. [read post]
25 Mar 2015, 4:42 am
Mylan stands for the proposition that “the mere act of placing a pharmaceutical product on the market, without more, cannot support a Lanham Act claim. [read post]
22 Mar 2015, 9:46 pm
Mylan Pharmaceuticals, Inc. 1:15-cv-00049; filed March 19, 2015 in the Northern District of West Virginia Bristol-Myers Squibb Co. v. [read post]
22 Mar 2015, 9:46 pm
Mylan Pharmaceuticals, Inc. 1:15-cv-00049; filed March 19, 2015 in the Northern District of West Virginia Bristol-Myers Squibb Co. v. [read post]
15 Mar 2015, 6:18 pm
The proposed bill reflects a basic misunderstanding of the pharmaceutical marketplace, and attempts to impose brand pharmaceutical provisions on generic drugs. [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
11 Jan 2015, 9:59 pm
Mylan Inc. et al. 1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Mylan Inc.; Agila Specialties Private Ltd.; Mylan Pharmaceuticals Inc. [read post]
20 Nov 2014, 4:48 am
” Among S&P 500 companies targeted in the 2015 New York City Funds campaign over multiple “priority issues” are Mylan (pay and governance), Nabors Industries (diversity, pay, and governance), Urban Outfitters (diversity and governance), Cimarex Energy (diversity and fossil fuel), Cabot Oil & Gas(diversity and fossil fuel), and Regeneron Pharmaceuticals (diversity and pay). [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
6 Nov 2014, 5:00 am
Mylan, Inc., 661 F. [read post]
1 Nov 2014, 12:47 pm
Mylan Pharmaceuticals Inc., C.A. [read post]
30 Oct 2014, 12:02 pm
“Some of the biggest generic drug companies — Mylan, Actavis and Teva Pharmaceutical Industries — have been aggressively snapping up other manufacturers in recent years,” Lazarus wrote, “reducing the number of players in the market. [read post]
21 Oct 2014, 12:00 am
Other recent pharmaceutical cases concerning inventive step There have been several cases in recent times where inventive step been determined in the context of a pharmaceutical invention. [read post]
13 Oct 2014, 8:46 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc.; Natco Pharma Ltd. [read post]
13 Oct 2014, 9:01 am
The Teva Pharmaceuticals case combines a core question about how the Federal Circuit reviews trial court decisions on the scope of patents, a new examination of a key 1996 Supreme Court precedent, an unrelenting battle among companies in the pharmaceutical business, and the right to control the sale of one of the most profitable medicines ever invented. [read post]
10 Oct 2014, 1:16 pm
JHP Pharmaceuticals, LLC v. [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
25 Aug 2014, 8:57 am
Mylan counterclaimed in respect of an eighth Orange Book patent. [read post]
18 Aug 2014, 6:48 am
Mylan Pharmaceuticals, Inc., et al., Civil Action No. 08-889-SLR (D.Del., August 14, 2014), the Court granted defendants’ motion for partial summary judgment of no willfulness with respect to their infringement of the patents-in-suit based upon defendants’ at risk launch of their generic versions of plaintiffs’ Amrix® products. [read post]
